Cannabis sativa L. has been cultivated throughout the world for industrial and medical purposes and is the most controversial plant ever exploited, with considerable discrepan- cies in the praise and disapproval it receives. Medical Cannabis prescriptions are on the increase in several countries where its therapeutic use is authorised due to its positive role in treating several pathologies even if it represents a multifaceted reality in terms of application. There are at least 550 identified compounds in C. sativa L., including more than 100 phytocannabinoids and 120 terpenes. The chemical complexity of its bioactive constituents highlights the need for standardised and well-defined analytical approaches able to characterise plant chemotype and herbal drug quality as well as to monitor the quality of pharmaceutical cannabis extracts and preparations. This research highlights the potential of using different analytical procedures involving the combination of headspace- solid-phase microextraction (HS-SPME) coupled to GC–MS and accelerated solvent extrac- tion (ASE) coupled to high resolution mass-spectrometry (HPLC-Q Orbitrap®) for the in- depth profiling of quality traits in authorised medical varieties of Cannabis sativa L. flos (Bediol®) and corresponding macerated oil preparations. This approach could add new knowledge to the field of “omic” analytical applications which are fundamental nowadays for Cannabis used for therapeutic remedies.

Quality Traits of Medical Cannabis sativa L. Inflorescences and Derived Products Based on Comprehensive Mass-Spectrometry Analytical Investigation / L. Calvi, R. Pavlovic, S. Panseri, L. Giupponi, V. Leoni, A. Giorgi - In: Recent Advances in Cannabinoid Research / [a cura di] W.J. Costain, R.B. Laprairie. - [s.l] : IntechOpen, 2019. - ISBN 9781838801519. - pp. 55-79 [10.5772/intechopen.79539]

Quality Traits of Medical Cannabis sativa L. Inflorescences and Derived Products Based on Comprehensive Mass-Spectrometry Analytical Investigation

R. Pavlovic;S. Panseri;L. Giupponi;V. Leoni;A. Giorgi
Ultimo
2019

Abstract

Cannabis sativa L. has been cultivated throughout the world for industrial and medical purposes and is the most controversial plant ever exploited, with considerable discrepan- cies in the praise and disapproval it receives. Medical Cannabis prescriptions are on the increase in several countries where its therapeutic use is authorised due to its positive role in treating several pathologies even if it represents a multifaceted reality in terms of application. There are at least 550 identified compounds in C. sativa L., including more than 100 phytocannabinoids and 120 terpenes. The chemical complexity of its bioactive constituents highlights the need for standardised and well-defined analytical approaches able to characterise plant chemotype and herbal drug quality as well as to monitor the quality of pharmaceutical cannabis extracts and preparations. This research highlights the potential of using different analytical procedures involving the combination of headspace- solid-phase microextraction (HS-SPME) coupled to GC–MS and accelerated solvent extrac- tion (ASE) coupled to high resolution mass-spectrometry (HPLC-Q Orbitrap®) for the in- depth profiling of quality traits in authorised medical varieties of Cannabis sativa L. flos (Bediol®) and corresponding macerated oil preparations. This approach could add new knowledge to the field of “omic” analytical applications which are fundamental nowadays for Cannabis used for therapeutic remedies.
Bediol®; terpenes; cannabinoids; GC-MS; HS-SPME; HPLC-Q-Exactive- Orbitrap-MS; Cannabis sativa L
Settore BIO/03 - Botanica Ambientale e Applicata
2019
https://www.intechopen.com/books/recent-advances-in-cannabinoid-research/quality-traits-of-medical-cannabis-sativa-l-inflorescences-and-derived-products-based-on-comprehensi
Book Part (author)
File in questo prodotto:
File Dimensione Formato  
Cannabis chapter.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.9 MB
Formato Adobe PDF
1.9 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/762551
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact